Suomi - suomi - Fimea (Suomen lääkevirasto)

abbott france s.a. - kalsium iodidum anhydricum,isoprenalini sulfas - mikstuura - yhdistelmävalmisteet

Euroopan unioni - suomi - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - rokotteet - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. käyttö tämä rokote tulee virallisten suositusten mukaisesti.

Euroopan unioni - suomi - EMA (European Medicines Agency)

elanco gmbh - valnemuliini - antiinfectives järjestelmälliseen käyttöön - pigs; rabbits - pigsthe hoito ja ennaltaehkäisy sikadysenterian. sian proliferatiivisen enteropatian (ileitis) kliinisten oireiden hoito. sikojen paksusuolen spiroketatoosin (koliitti) kliinisten oireiden ennaltaehkäisy, kun tauti on diagnosoitu karjassa. sian keuhkoahtaumataudin hoito ja ehkäisy. suositellulla annoksella 10-12 mg/kg ruumiinpainoa keuhkovauriot ja painonlasku vähenevät, mutta mykoplasmainfektio mycoplasma hyopneumoniae ei ole eliminoitu. rabbitsreduction kuolleisuus epidemian aikana kani epitsoottisen suolisairaus (ere). hoito on aloitettava varhaisessa vaiheessa, kun ensimmäinen kani on diagnosoitu taudin kliinisesti.

Suomi - suomi - Fimea (Suomen lääkevirasto)

ibsa farmaceutici italia s.r.l - urofollitropin - injektiokuiva-aine ja liuotin, liuosta varten - 75 iu/ml - urofollitropiini

Suomi - suomi - Fimea (Suomen lääkevirasto)

ibsa farmaceutici italia s.r.l - urofollitropin - injektiokuiva-aine ja liuotin, liuosta varten - 150 iu/ml - urofollitropiini

Suomi - suomi - Fimea (Suomen lääkevirasto)

ibsa farmaceutici italia s.r.l - urofollitropin - injektiokuiva-aine ja liuotin, liuosta varten - 75 iu/ml - urofollitropiini

Suomi - suomi - Fimea (Suomen lääkevirasto)

ibsa farmaceutici italia s.r.l - urofollitropin - injektiokuiva-aine ja liuotin, liuosta varten - 150 iu/ml - urofollitropiini

Suomi - suomi - Fimea (Suomen lääkevirasto)

ibsa farmaceutici italia s.r.l - urofollitropin - injektiokuiva-aine ja liuotin, liuosta varten - 225 iu - urofollitropiini

Suomi - suomi - Fimea (Suomen lääkevirasto)

ibsa farmaceutici italia s.r.l - urofollitropin - injektiokuiva-aine ja liuotin, liuosta varten - 300 iu - urofollitropiini

Suomi - suomi - Fimea (Suomen lääkevirasto)

accord healthcare b.v. accord healthcare b.v. - clarithromycinum - tabletti, kalvopäällysteinen - 250 mg - klaritromysiini